EUVIMEDEUVIMED entdecken
Crossref

Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries

Pojsakorn Danpanichkul iD, Yanfang Pang, Primrose Tothanarungroj, Disatorn Dejvajara, Donghee Kim, Preenapun Saokhieo, Kanokphong Suparan, Mark D Muthiah, Kwanjit Duangsonk, Diego Olavarria Bernal, Rashid N Lui, Karn Wijarnpreecha und 5 weitere

Cancer · 01.01.2026 · 132 (1)

DOI: 10.1002/cncr.70245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 30.12.2025. Verfasst von Pojsakorn Danpanichkul und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastrointestinal (GI) cancer remains a major global health challenge. This study provides updated 2022 estimates of GI cancer incidence and mortality worldwide, along with projections of incident cases and deaths through 2050 to inform cancer control strategies.

Methods

In this population‐based study, data from the GLOBOCAN 2022 database were used to examine incidence and deaths associated with GI cancer. By using global demographic projections, this study estimated the projected number of incident cases and deaths until the year 2050.

Results

By 2050, the global burden of GI cancer is projected to reach 9.06 million incident cases (+85%) and 6.42 million deaths (+93%) from 2022. Increases in incidence are projected for both females (+87%) and males (+83%), as are increases in mortality for both females (+97%) and males (+91%). Whereas the Western Pacific region will have the highest absolute burden, with 3.88 million new cases and 2.79 million deaths, the greatest relative increase is expected in Africa, with incidence and deaths rising by 157% and 160%, respectively. As measured by the Human Development Index (HDI), the steepest increases are projected in low (+151% incidence; +152% deaths) and medium (+112% incidence; +114% deaths) HDI countries. Overall, all GI cancer types are projected to increase, led by pancreatic cancer in incidence (+95%) and colorectal cancer in deaths (+103%).

Conclusions

GI cancer incidence and deaths are expected to nearly double by 2050, with increases across sexes, cancer types, and regions, especially in lower HDI countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal NeoplasmsHumansFemaleMaleIncidenceGlobal HealthMiddle AgedAgedAdultAdolescentYoung Adult

Stichwörter der Autor:innen

cancercolorectal cancerepidemiologygastrointestinal oncologypancreatic cancer

Autor:innen und Institutionen

  • Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
  • Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China.
  • National Immunological Laboratory of Traditional Chinese Medicine, Baise, Guangxi, China.
  • Center for Medical Laboratory Science, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China.
  • Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA.

ORCID-Profile: Pojsakorn Danpanichkul, Ghassan K Abou-Alfa, Amit G Singal, Ju Dong Yang

Förderung

  • NCI NIH HHS
  • NIH HHS

Zitieren

APA

Danpanichkul, P., Pang, Y., Tothanarungroj, P., Dejvajara, D., Kim, D., Saokhieo, P., Suparan, K., Muthiah, M. D., Duangsonk, K., Bernal, D. O., Lui, R. N., Wijarnpreecha, K., Abou-Alfa, G. K., Wallace, M. B., Roberts, L. R., Singal, A. G., & Yang, J. D. (2026). Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries. Cancer, 132(1). https://doi.org/10.1002/cncr.70245

Vancouver

Danpanichkul P, Pang Y, Tothanarungroj P, Dejvajara D, Kim D, Saokhieo P, et al. Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries. Cancer. 2026;132(1). doi:10.1002/cncr.70245

BibTeX
@article{Danpanichkul2026,
  author = {Danpanichkul, Pojsakorn and Pang, Yanfang and Tothanarungroj, Primrose and Dejvajara, Disatorn and Kim, Donghee and Saokhieo, Preenapun and Suparan, Kanokphong and Muthiah, Mark D and Duangsonk, Kwanjit and Bernal, Diego Olavarria and Lui, Rashid N and Wijarnpreecha, Karn and Abou-Alfa, Ghassan K and Wallace, Michael B and Roberts, Lewis R and Singal, Amit G and Yang, Ju Dong},
  title = {Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries},
  journal = {Cancer},
  year = {2026},
  volume = {132},
  number = {1},
  doi = {10.1002/cncr.70245}
}
Kostenlos starten →